Comprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations
Abstract
Abstract Ampullary somatostatin-producing D-cell neuroendocrine tumors are rare neoplasms that may be associated with type 1 neurofibromatosis. The molecular features of sporadic ampullary somatostatin-producing D-cell neuroendocrine tumors (SAMSOM-NETs) remain poorly characterized. We performed an integrated morphological, immunohistochemical, and genomic analysis of a multicenter series of SAMSOM-NETs. Eleven cases were included (73% male; median age: 63 years). All six patients who underwent lymphadenectomy were staged as pN1, and liver metastases were found in three cases; however, no tumor-related deaths occurred (median follow-up: 104 months). Common histologic features that can pose diagnostic challenges in the differential diagnosis with adenocarcinoma included a tubulo-glandular architecture (100%), periodic Acid–Schiff (PAS)-positive intraluminal mucin (73%), MUC1 expression (100%), and carcinoembryonic antigen (45%) expression. All tumors exhibited dot-like cytoplasmic reactivity for cytokeratins (CK) CAM5.2 or CK AE1/AE3, and 82% were CK7-positive. ISL1 and PDX1 were diffusely expressed in all cases, while CDX2 was positive in 54% and ARX showed only focal expression in four tumors. Genomic profiling revealed microsatellite stability and low tumor mutational burden. Alterations in the RAS pathway, including HRAS mutations (4 cases, 36%), a KRAS mutation (1 case), and NF1 alterations (one case), were identified in 54% of cases and in all tumors with liver metastases. Additional molecular findings included a CDK12 splice-site alteration and an NTRK3 :: PRDM4 fusion. Potentially actionable alterations affecting kinase-related pathways were detected in 64% of tumors. Our findings support SAMSOM-NET as a peculiar neuroendocrine tumor subtype showing distinctive histologic and molecular characteristics with potential diagnostic and therapeutic implications.
// Source
Authors: Alessandro Vanoli, Erica Travaglino, Frediano Inzani, Tommaso Orione, Federica Grillo, P. Parente, Paola Spaggiari, Silvia Uccella, Alessandro Zerbi, Anna Caterina Milanetto, Mauro Lecca, Andrea Peri, Antonio Di Sabatino, Marco Paulli, Stefano La Rosa, Matteo Fassan, Edoardo Errichiello
Institutions: University of Padua, Policlinico San Matteo Fondazione, Istituti di Ricovero e Cura a Carattere Scientifico, University of Pavia, Humanitas University, IRCCS Humanitas Research Hospital, University of Genoa, Ospedale Policlinico San Martino, Saint Camillus International University of Health and Medical Sciences, University of Insubria, American Association for the Surgery of Trauma, Istituto Oncologico Veneto, Ospedali Riuniti di Foggia, Fondazione Istituto Neurologico Nazionale Casimiro Mondino